ECAR Trademark

Trademark Overview


On Friday, June 7, 2024, a trademark application was filed for ECAR with the United States Patent and Trademark Office. The USPTO has given the ECAR trademark a serial number of 98590882. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, December 27, 2024. This trademark is owned by KSQ Therapeutics, Inc.. The ECAR trademark is filed in the Pharmaceutical Products category with the following description:

Cells for medical use; pharmaceuticals and therapeutics
ecar

General Information


Serial Number98590882
Word MarkECAR
Filing DateFriday, June 7, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, December 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesCells for medical use; pharmaceuticals and therapeutics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKSQ Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events


Event DateEvent Description
Friday, June 7, 2024NEW APPLICATION ENTERED
Friday, December 6, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 17, 2024ASSIGNED TO EXAMINER
Friday, December 27, 2024NON-FINAL ACTION WRITTEN
Friday, December 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, December 27, 2024NON-FINAL ACTION E-MAILED